Role of Cytosolic Phospholipase A2 in Prostaglandin E 2 Production by Lung Fibroblasts

American Journal of Respiratory Cell and Molecular Biology

Volumn 30, Issue 1, 2004, Pages 91-100

  Ghosh, Moumita ^b   Stewart, Allison ^b   Tucker, Dawn E ^b   Bonventre, Joseph V ^b   Murphy, Robert C ^b   Leslie, Christina C ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIMYCIN; COLLAGEN; CYCLOOXYGENASE 2; LYSOPHOSPHATIDIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPASE A2; PLATELET DERIVED GROWTH FACTOR; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL IMMORTALIZATION; CELL STIMULATION; CONTROLLED STUDY; CYTOSOL; ENZYME DEFICIENCY; ENZYME SYNTHESIS; FIBROBLAST; LUNG FIBROBLAST; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; WILD TYPE;

ANIMALS; ARACHIDONIC ACID; BASE SEQUENCE; CELL LINE, TRANSFORMED; CYCLOOXYGENASE 2; CYTOSOL; DINOPROSTONE; DNA PRIMERS; FIBROBLASTS; ISOENZYMES; LUNG; MICE; MICE, INBRED C57BL; PHOSPHOLIPASES A; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; UP-REGULATION;

ANIMALIA;

EID: 0346373592     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2003-0005OC     Document Type: Article

References (39)

1. Selman, M., T. E. King, and A. Pardo. 2001. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med. 134:136-151.
2. Coker, R. K., and G. J. Laurent. 1998. Pulmonary fibrosis: cytokines in the balance. Eur. Respir. J. 11:1218-1221.
3. Lasky, J. A., and A. R. Brody. 2000. Interstitial fibrosis and growth factors. Environ. Health Perspect. 108:751-762.
4. McAnulty, R. J., N. A. Hernandez-Rodriguez, S. E. Mutsaers, R. K. Coker, and G. J. Laurent. 1997. Indomethacin suppresses the anti-proliferative effects of transforming growth factor-β isoforms on fibroblast cell cultures. Biochem. J. 321:639-643.
5. Funk, C. D. 2001. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294:1871-1875.
6. Korn, J. H., P. V. Halushka, and E. C. LeRoy. 1980. Mononuclear cell modulation of connective tissue function: suppression of fibroblast growth by stimulation of endogenous prostaglandin production. J. Clin. Invest. 65:543-554.
7. Goldstein, R. H., and P. Polgar. 1982. The effect and interaction of bradykinin and prostaglandins on protein and collagen production by lung fibroblasts. J. Biol. Chem. 257:8630-8633.
8. Keerthisingam, C. B., R. G. Jenkins, N. K. Harrison, N. A. Hernandez-Rodriguez, H. Booth, G. J. Laurent, S. L. Hart, M. L. Foster, and R. J. McAnulty. 2001. Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-β in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice. Am. J. Pathol. 158:1411-1422.
9. 2 and to express cyclooxygenase-2. J. Clin. Invest. 95: 1861-1868.
10. Bonner, J. C., A. B. Rice, J. L. Ingram, C. R. Moomaw, A. Nyska, A. Bradbury, A. R. Sessoms, P. C. Chulada, D. L. Morgan, D. C. Zeldin, and R. Langenbach. 2002. Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis. Am. J. Pathol. 161:459-470.
11. Wilborn, J., M. Bailie, M. Coffey, M. Burdick, R. Strieter, and M. Peters-Golden. 1996. Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis. J. Clin. Invest. 97:1827-1836.
12. Peters-Golden, M., M. Bailie, T. Marshall, C. Wilke, S. H. Phan, G. B. Toews, and B. B. Moore. 2002. Protection from pulmonary fibrosis in leukotriene-deficient mice. Am. J. Respir. Crit. Care Med. 165:229-235.
13. 2 enzymes: classification and characterization. Biochim. Biophys. Acta 1488:1-19.
14. 2. J. Biol. Chem. 272:16709-16712.
15. 2 in allergic response and parturition. Nature 390:618-622.
16. 2. Nat. Immunol. 1:42-46.
17. 2 in bleomycin-induced pulmonary fibrosis. Nat. Med. 8:480-484.
18. 2. Nature 390:622-625.
19. Bruce, M. C., C. E. Honaker, and R. J. Cross. 1999. Lung fibroblasts undergo apoptosis following alveolarization. Am. J. Respir. Cell. Mol. Biol. 20: 228-236.
20. Eickelberg, O., E. Kohler, F. Reichenberger, S. Bertschin, T. Woodtli, P. Erne, A. P. Perruchoud, and M. Roth. 1999. Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-β1 and TGF-β3. Am. J. Physiol. 276:L814-L824.
21. 2 is phosphorylated and activated by MAP kinase. Cell. 72: 269-278.
22. 2 in regulating arachidonic acid release in macrophages. J. Biol. Chem. 273:8203-8211.
23. Racke, K., R. Hammermann, and U. R. Juergens. 2000. Potential role of EDG receptors and lysophospholipids as their endogenous ligands in the respiratory tract. Pulm. Pharmacol. Ther. 13:99-114.
24. 2 in human fibroblasts. J. Biol. Chem. 267:23451-23454.
25. 2 in rheumatoid synovial fibroblasts. Biochem. Biophys. Res. Commun. 184:712-718.
26. 2 as defined by gene knockouts. Biochim. Biophys. Acta 1488:139-148.
27. 2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem. 275:32783-32792.
28. Polyak, K., Y. Xia, J. L. Zweier, K. W. Kinzler, and B. Vogelstein. 1997. A model for p53-induced apoptosis. Nature 389:300-305.
29. Pipas, J. M., and A. J. Levine. 2001. Role of T antigen interactions with p53 in tumorigenesis. Semin. Cancer Biol. 11:23-30.
30. Tilley, S. L., T. M. Coffman, and B. H. Koller. 2001. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest. 108:15-23.
31. 2. J. Exp. Med. 196:349-357.
32. 2 gene. Am. J. Physiol. Lung Cell. Mol. Physiol. 278:L649-L657.
33. 2 mRNA in lung fibroblasts and endothelial cells in culture. Biochem. Biophys. Res. Commun. 197:1465-1474.
34. 2 translocation to internal membranes. J. Biol. Chem. 276:30150-30160.
35. 2 by MNK1-related protein kinases. J. Biol. Chem. 275:37542-37551.
36. 2. J. Cell. Biol. 145:1219-1232.
37. 2 biosynthesis. J. Biol. Chem. 275:32775-32782.
38. 2 is mediated by inducible nitric oxide synthase activation of the constitutive cyclooxygenase and induction of membrane-associated prostaglandin E synthase. J. Immunol. 167:3962-3971.
39. 2 production. J. Biol. Chem. 277:36897-36903.